| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102333
Status
Published
Date of creation
2011-09-22 19:42 UTC (andrew.bowers@cbd.int)
Date of last update
2011-11-11 16:49 UTC (andrew.bowers@cbd.int)
Date of publication
2011-11-11 16:49 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
Country
  • Guinea
Contact officer for report
Coordinates
Madame Hawa DIALLO
Directrice Nationale Adjointe du Bureau de Stratégie et de Planification, Point Focal National du BCH, Coordinatrice Nationale de la Biosécurité
Ministère Délégué à l'Environnement, aux Eaux et Forêts
B.P 3118
Conakry
Guinea
Phone:+224 68125297,+224 60285993
Email:loubahawa@yahoo.fr
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
FR
- Direction Nationale de la Santé Publique                                     - Direction nationale de Pharmacie - Direction Nationale de l'Agriculture - Institut de Recherche Agronomique de Guinée - Chambre Nationale d'Agriculture  - Direction Nationale de la Pêche Continentale - Direction Nationale de la Pêche maritime - Direction Nationale de l'Industrie - Direction Nationale du Commerce _Chambre Nationale de Commerce et d'Industrie de Guinée -l'Office de contrôle de Qualité et des Normes - Direction Nationale de la Production Animale - Direction Nationale de l'Environnement - Direction Nationale des Eaux et Forêts - Bureau de Stratégie et de Planification - Direction nationale de l'Assainissement - l'Office Guinéen de la Biodiversité et des Aires protégées - ONG/APCAM - Conféderation des Paysans de Guinée - Centre d'observation et de Suivi Environnemental
Submission
10. Date of submission
2011-09-23
11. Time period covered by this report
Start date
2007
Time period covered by this report
End date
2011
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is partially in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • No
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • No
21. Here you may provide further details on the implementation of Article 2 in your country:
FR
A ce titre, le Cadre national de biosécurité a été validé en atelier de partenaires  et soumis au Gouvernement pour approbation. Un projet de Loi  relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés  a été élaboré et transmis à l'Assemblée Nationale
Au titre du personnel affecté au programme de travail, il y a notamment
- le point focal national du Protocole sur la biosécurité,
  - le point focal national du BCH
- les points focaux sectoriels du BCH (Direction Nationale de l'Agriculture, Direction Nationale de l'Elevage, Département de Biologie / Université de Conakry,  Office de contrôle de normes et qualité )
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
FR
Au  titre du projet de Loi  relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés en République de Guinée, les mouvements transfrontières, la manipulation et l'utilisation d'organismes vivants modifiés, ainsi que les produits pharmaceutiques dérivés des organismes génétiquement modifiés (OGM) seront réglementés.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • No
26. Does your country regulate the contained use of LMOs?
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
FR
Le projet de Loi   relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés  en République de Guinée, en ses articles 11à 16  règlemente le transit et l'utilisation en milieu confiné des OGM
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • No
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes
34. Does your country have the capacity to detect and identify LMOs?
  • No
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • Yes
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • Yes
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
FR
Concernant l'application des articles 7 à 10 sur l'Accord préalable en connaissance de cause et l'introduction intentionnelle des OVM dans l'environnement, des mesures sont établies dans le cadre national de biosécurité et prévues dans le projet de Loi relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés en République de Guinée
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • Yes
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • No
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
FR
En République de Guinée, la Loi L/95/ 046/ CTRN du 29 août 1995, portant  Code de l'élevage et des produits animaux (article 2), la Loi L96/007/AN du 22 juillet 1996 (article 27)  portant organisation de la pêche continentale et la Loi L97/021/AN du 19 juin 1997 portant Code de la santé publique, traitent en partie de l'utilisation sur le territoire national d'OGM destinés à  l'alimentation humaine ou animale ou à être transformés.
Par rapport à la question 52, le projet de Loi relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés en République de Guinée prévoit des obligations juridiques sur l'exactitude des informations à fournir par le demandeur (articles 3 et 4).
Pour la Procédure de prise de décision, le mécanisme est établi dans le cadre national de biosécurité. Ce mécanisme implique aussi bien l'exportateur, l'autorité nationale compétente, le comité national de biosécurité, le BCH national, le BCH international, les comités institutionnels de biosécurité et le public.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
FR
Concernant l'application de cet article 12, le cadre national  de biosécurité et le projet de Loi relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés ne prévoient pas de mécanismes de reconsidération et de modification d'une décision concernant un mouvement transfrontière intentionnel d'OGM. Ce vide juridique est à combler.
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • Yes
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
FR
Le cadre national de biosécurité a établi un mode d'application de la procédure simplifiée; cependant le projet de Loi relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés est muette sur cette question. Ce vide juridique est à combler.
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
FR
La République de Guinée adhère à l'initiative de la CEDEAO relative au développement  d'un cadre sous - régional de biosécurité concerté. C'est dans ce cadre que le projet de Règlement sous - régional de biosécurité a été examiné et validé lors de l'atelier national organisé à conakry  les 21, 22, 23 et 24 mars 2011. En même temps, la Guinée a participé  à l'examen du projet de Loi modéle sur la sécurité en biotechnologie de l'Union Africaine.
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • Yes
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • No
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • No
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • No
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • No
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • No
93. Here you may provide further details on the implementation of Article 15 in your country:
FR
Le mécanisme d'évaluation des risques est pris en compte dans le cadre national de biosécurité et dans le projet de Loi relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés en République de Guinée. Cependant aucune notification n'a été enregistrée et en plus la Guinée manque de compétences pour mener cette activité.
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • No
94.2) LMOs intended for direct use as food or feed, or for processing?
  • No
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
FR
Les textes de base de la Guinée prévoient un mécanisme de gestion des risques. Cependant par manque de compétences pour l'identification des OGM, ce mécanisme n'est pas mis en œuvre
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • Yes
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • Yes
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • Yes
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
FR
Le cadre national de biosécurité et le projet de  Loi relative au contrôle des risques liés à l'usage  des organismes génétiquement modifiés en République de Guinée intègrent les mouvements transfrontières non intentionnels et mesures d'urgence
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • No
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • No
114. Has your country established procedures for the sampling and detection of LMOs?
  • Yes, to some extent
115. Here you may provide further details on the implementation of Article 18 in your country:
FR
Le principe sur la fourniture de documents accompagnant les OGM destinés à être utilisés directement dans l'alimentation humaine ou  animale ou à être transformés est posé dans le projet de Loi relative au contrôle des risques liés à l'usage des organismes génétiquement modifiés en République de Guinée.

Les détails sur l'application de ce principe seront précisés par voie réglementaire.

En ce qui concerne les procédures de détection des OGM, le principe est retenu dans le projet de Loi, mais les textes d'application ne sont pas élaborés.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes, to some extent
123. Here you may provide further details on the implementation of Article 19 in your country:
FR
Les correspondants nationaux du Protocole et du BCH sont désignés par des actes officiels et soumis au BCH.

Le Ministère Délégué à l'Environnement, aux Eaux et Forêts assume  les fonctions de l'Autorité Nationale Compétente.

Les Points focaux sectoriels du BCH sont désignés aux  niveaux de l'Office de contrôle de qualités et normes, des Directions nationales de  l'Elévage et de l'Agriculture ainsi qu'à l'Université de Conakry.

Le Comité national de biosécurité est mis en place; cependant, les Comités institutionnels de biosécurité prévus dans le cadre national de biosécurité ne sont pas mis en place
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available but only partially available in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information not available
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information available but not in the BCH
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available but only partially available in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
128. Has your country experienced difficulties accessing or using the BCH?
  • Yes
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Yes
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
FR
Les préoccupations exprimées à cet article 20 ne sont pas entièrement prises en compte dans les textes nationaux.

Toutefois,  pour des raisons  de sécurité et/ou par manque de capacités techniques et technologiques,  tous les mouvements transfrontières d'OGM sont soumis à la procédure régulière de prise de décision en toute connaissance de cause. 

Aussi, les dispositions concernant les décisions finales sur l'utilisation dans le territoire national  d'OGM destinés à l'alimentation humaine ou animale ou à être transformés seront intégrées des les textes nationaux.

Le point ''q'' du questionnaire 124 visant l'article 30, paragraphe 3c du Protocole  se rapporte plutôt aux organes subsidiaires et non à l'évaluation des risques ou études environnementales des OVM.

Pour l'utilisation du BCH, le point focal national BCH Guinée est confronté à des difficultés notamment en ce qui concerne la connection internet, l'interconnection interne avec les points focaux sectoriels du BCH et l'exploitation des données et informations qui sont le plus souvent en anglais.
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • In some cases only
134. Here you may provide further details on the implementation of Article 21 in your country:
FR
Les procédures sur la confidentialité des informations sont prévues à l'article 30 du  projet de Loi relative aux contrôles des risques liés à l'usage des OGM en Guinée qui est soumis pour adoption. Toutefois, ce  projet de Loi prévoit que certaines informations  ne peuvent être tenues confidentielles.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Regional channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Easy
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Information exchange and data management including participation in the Biosafety Clearing-House
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • Yes
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
FR
Une stratégie et un plan d'action pour  la création de capacités sont développés dans le document de projet de cadre national de biosécurité à travers les projets I, III et IV qui portent respectivement sur  le renforcement des capacités humaines, institutionnelles et l'implication des populations dans la prévention et la gestion des risques biotechnologiques. Dans le même document, un mécanisme pour la sensibilisation des populations en matière de prévention des risques biotechnologiques a été défini.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
152. Has your country established a biosafety website?
  • No
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes, to a limited extent
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • No
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • No
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • No
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
FR
Le projet de cadre national de biosécurité a défini une stratégie nationale et un plan d'action pour la gestion des risques biotechnologiques qui intègrent les mécanismes d'information, de sensibilisation et d'implication du public.
Cependant pour la mise en œuvre des plans d'action, il est absolument nécessaire de développer et mettre en place un site web national sur la biotechnologie et la biosécurité afin de favoriser le partage des informations
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
167. Here you may provide further details on the implementation of Article 24 in your country:
FR
La Guinée est Partie au Protocole depuis 0ctobre 2005
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
FR
Les mouvements transfrontières illicites n'ont pas été traités dans les textes de base.

Toutefois, ces aspects seront pris en compte avant l'adoption du cadre national de biosécurité et la promulgation du projet de Loi.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • No
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
178. Here you may provide further details on the implementation of Article 26 in your country:
FR
Vu la pertinence des questions liées aux considérations socio-économiques  dans la gestion des risques biotechnologiques, ces aspects seront pris en considération avant l'adoption  et la promulgation des textes nationaux de base.
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • No
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
FR
La Guinée n'a pas signé le protocole additionnel de Nagoya-Kuala Lumpur.

Cependant, un dossier d'adhésion est en cours de préparation par le Ministère Délégué à l'Environnement, aux Eaux et Forêts, pour soumission au Ministère des Affaires Etrangères.
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes, First report only
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • Sans objet
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
FR
La Guinée, Partie au Protocole de Cartagena sur la prévention des risques biotechnologiques  a déjà préparé le cadre national de biosécurité, élaboré le projet de Loi sur le contrôle des risques liés à l'usage des organisme génétiquement modifiés et mis en place le BCH national, des BCH sectoriels dans certaines structres partenaires.

Malgré  cette volonté manifeste des autorités de respecter et de faire appliquer les dispositions du Protocole de Cartagena, des contraintes liées à l'instabilité politique et sociale que le pays a connu ces dernières années n'ont pas encore permis l'adoption des documents de base.

Aux contraintes ci - dessus citées, il faut ajouter la faiblesse des capacités matérielles et humaines.

Re: Q. 14- La République de Guinée a  signé et ratifié  le Protocole respectivement le 29 janvier 2000 à Nairobi et le 28 octobre 2005

Q. 136- Voies multilatérales aussi
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
FR
Le format du rapport est approprié pour ce genre de travail.

En outre, le renvoi de la question 124 "q" (article 20) ne correspond pas à l'article 30 parapgraphe 3C visé. Celui-ci traîte plutôt des Organes Subsidiaires.